Aroon Hingorani
Overview
Explore the profile of Aroon Hingorani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
6978
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noordam R, Wang W, Nagarajan P, Wang H, Brown M, Bentley A, et al.
medRxiv
. 2024 Sep;
PMID: 39281768
We performed large-scale genome-wide gene-sleep interaction analyses of lipid levels to identify novel genetic variants underpinning the biomolecular pathways of sleep-associated lipid disturbances and to suggest possible druggable targets. We...
2.
Katsoulis M, Leyrat C, Hingorani A, Gomes M
Epidemiology
. 2024 Jul;
35(5):730-733.
PMID: 39024012
No abstract available.
3.
Lau C, Manou M, Markozannes G, Ala-Korpela M, Ben-Shlomo Y, Chaturvedi N, et al.
Aging Cell
. 2024 Apr;
23(7):e14164.
PMID: 38637937
Metabolomic age models have been proposed for the study of biological aging, however, they have not been widely validated. We aimed to assess the performance of newly developed and existing...
4.
Lau C, Manou M, Markozannes G, Ala-Korpela M, Ben-Shlomo Y, Chaturvedi N, et al.
medRxiv
. 2023 Nov;
PMID: 37986811
Metabolomic age models have been proposed for the study of biological aging, however they have not been widely validated. We aimed to assess the performance of newly developed and existing...
5.
Olvera-Barrios A, Rudnicka A, Anderson J, Bolter L, Chambers R, Warwick A, et al.
Br J Ophthalmol
. 2023 Oct;
107(12):1839-1845.
PMID: 37875374
Background/aims: The English Diabetic Eye Screening Programme (DESP) offers people living with diabetes (PLD) annual screening. Less frequent screening has been advocated among PLD without diabetic retinopathy (DR), but evidence...
6.
Sae-Jie W, Supasai S, Kivimaki M, Price J, Wong A, Kumari M, et al.
BMC Med
. 2023 Sep;
21(1):340.
PMID: 37667256
Background: Ketone bodies (KBs) are an alternative energy supply for brain functions when glucose is limited. The most abundant ketone metabolite, 3-β-hydroxybutyrate (BOHBUT), has been suggested to prevent or delay...
7.
Hamilton F, Thomas M, Arnold D, Palmer T, Moran E, Mentzer A, et al.
PLoS Med
. 2023 Jan;
20(1):e1004174.
PMID: 36716318
Background: Sepsis is characterised by dysregulated, life-threatening immune responses, which are thought to be driven by cytokines such as interleukin 6 (IL-6). Genetic variants in IL6R known to down-regulate IL-6...
8.
Patel R, Denaxas S, Howe L, Eggo R, Shah A, Allen N, et al.
PLoS One
. 2022 Apr;
17(4):e0264828.
PMID: 35381005
Importance: A lack of internationally agreed standards for combining available data sources at scale risks inconsistent disease phenotyping limiting research reproducibility. Objective: To develop and then evaluate if a rules-based...
9.
Kuan V, Warwick A, Hingorani A, Tufail A, Cipriani V, Burgess S, et al.
JAMA Ophthalmol
. 2021 Nov;
139(12):1299-1306.
PMID: 34734970
Importance: Advanced age-related macular degeneration (AMD) is a leading cause of blindness in Western countries. Causal, modifiable risk factors need to be identified to develop preventive measures for advanced AMD....
10.
Lai A, Chang W, Parisinos C, Katsoulis M, Blackburn R, Shah A, et al.
BMC Med Inform Decis Mak
. 2021 Oct;
21(1):281.
PMID: 34641870
Background: An Informatics Consult has been proposed in which clinicians request novel evidence from large scale health data resources, tailored to the treatment of a specific patient. However, the availability...